## **Core Concept**
The question tests knowledge of antihypertensive drugs and their safety profiles during pregnancy. Pregnancy-induced hypertension is a significant concern, and the choice of antihypertensive medication is crucial to ensure both maternal and fetal safety. Certain antihypertensive drugs are contraindicated in pregnancy due to their potential to cause harm to the fetus.

## **Why the Correct Answer is Right**
The correct answer, , is an angiotensin-converting enzyme (ACE) inhibitor. ACE inhibitors are known to be contraindicated in pregnancy, particularly in the second and third trimesters, due to the risk of fetal harm. They can cause fetal hypotension, renal failure, and skull hypoplasia. The mechanism involves the inhibition of angiotensin-converting enzyme, which plays a critical role in the renin-angiotensin-aldosterone system (RAAS), affecting blood pressure regulation and fluid balance.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option might represent a different class of antihypertensive drugs, such as calcium channel blockers or beta-blockers, which are generally considered safer during pregnancy.
- **Option B:** - This could be another class of drugs, like alpha-blockers or centrally acting agents, which might not have the same level of risk as ACE inhibitors in pregnancy.
- **Option D:** - This option might represent a drug that is actually used in pregnancy-induced hypertension, such as methyldopa, which is often considered a first-line treatment due to its safety profile.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that ACE inhibitors and angiotensin receptor blockers (ARBs) are contraindicated in pregnancy due to their association with fetal risks. Methyldopa, labetalol, and nifedipine are commonly used and considered relatively safe for managing hypertension in pregnancy.

## **Correct Answer:** .